• Allergic asthma immunotherapy, with Dr. Klaus Bønnelykke

  • Apr 17 2024
  • Length: 21 mins
  • Podcast

Allergic asthma immunotherapy, with Dr. Klaus Bønnelykke

  • Summary

  • Asthma prevalence is increasing around the world, and is theorised to be due to a number of environmental factors. One such factor is a sensitivity to house dust mite (HDM) allergens, which is common in asthma patients. Dr. Klaus Bønnelykke (1) joins the podcast to speak with Dr. Kate Diomede about this topic, following the publication of the paper, "Genetic and T2 biomarkers linked to the efficacy of HDM sublingual immunotherapy in asthma".

    (1) Copenhagen Prospective Studies on Asthma in Childhood, Copenhagen University Hospital, Copenhagen, Denmark

    Please engage in the conversation through the social media channels (Twitter - @ThoraxBMJ; Facebook - Thorax.BMJ) and subscribe on your preferred platform, to get the latest episodes directly on your device each month. We would love to hear your thoughts on the podcast, you can leave a review on Apple Podcasts or Spotify.

    Show more Show less
activate_Holiday_promo_in_buybox_DT_T2

What listeners say about Allergic asthma immunotherapy, with Dr. Klaus Bønnelykke

Average customer ratings

Reviews - Please select the tabs below to change the source of reviews.